Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 1004-1009

  Guardiola, Philippe ^a   Esperou, Helene ^a   Cazals Hatem, Dominique ^a   Ifrah, Norbert ^b   Jouet, Jean Pierre ^c   Buzyn, Agnes ^d   Sutton, Laurent ^e   Gratecos, Nicole ^f   Tilly, Herve ^g   Lioure, Bruno ^h   Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f University of Côte d'Azur   (France)

^g Centre Becquerel   (France)

^h HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Agnogenic myeloid metaplasia; Allogeneic bone marrow transplantation; Myeloproliferative disorder; Primary myelofibrosis

Indexed keywords

CYCLOSPORIN A; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MYELOID METAPLASIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 9844255048     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3073124.x     Document Type: Article

References (48)

1. Anderson, J.E., Appelbaum, F.R., Chauncey, T.R. & Storb, R. (1995) Allogeneic bone marrow transplantation for polycythemia vera, agnogenic myeloid metaplasia, and essential thrombocytosis: a series of 13 patients. Blood, 86, (Suppl. 1), 388a (abstract 1540).
2. Bandini, G., Ljungman, P., Arcese, G., Van Rhee, F., Corbett, R. & Patton, W.N., on behalf of the Chronic Leukaemia Working Party of the EBMT (1994) Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplantation, 13, 105 (abstract 41).
3. Barosi, G., Ambrosetti, A., Buratti, A., Finelli, C., Liberato, N.L., Quaglini, S., Ricetti, M.M., Visani, G., Tura, S. & Ascari, E. (1993) Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia, 7, 200-206.
4. Barosi, G., Liberato, L.N., Costa, A., Buratti, A., Di Dio, F., Salvatore, S. & Ascari, E. (1990) Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia. European Journal of Haematology, 45, (Suppl. 52), 12-14.
5. Barosi, G., Quaglini, S., Petti, C., Grossi, A., Pogliani, E., Leoni, P., Rotoli, B., Finelli, C., Foa, P., Ambrosetti, A., Rodeghiero, F., Centra, A., Gaurnone, R. & Liberato, N.L. (1995) Risk factors for blastic transformation in myelofibrosis with myeloid metaplasia (MMM). Blood, 86, (Suppl. 1), 790a (abstract 3147).
6. Benbassat, J., Gilon, D. & Penchas, S. (1990) The choice between splenectomy and medical treatment in patients with advanced primary myelofibrosis. American Journal of Haematology, 33, 128-135.
7. Besa, E.C., Nowell, P.C., Geller, N.L. & Gardner, F.H. (1982) Analysis of the androgen response of 23 patients with primary myelofibrosis. Cancer, 49, 308-313.
8. Cahn, J.Y., Plouvier, E., Flesch, M., Carbillet, J.P. & Hervé, P. (1987) T-cell-depleted allogeneic hone marrow transplantation in a case of childhood idiopathic myelofibrosis. Bone Marrow Transplantation, 2, 209-211.
9. Cehrelli, C., Ezdinli, E.Z., Li, C.Y. & Krmpotic, E. (1976) Blastic phase of primary myelofibrosis simulating malignant lymphoma. Cancer, 38, 1297-1305.
10. Chabannon, C., Pegourie, B., Sotto, J.J. & Hollard, D. (1990) Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia. Nouvelle Revue Française d'Hématologie, 32, 165-167.
11. Creemers, G.J., Löwenberg, B. & Hagenbeek, A. (1992) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 82, 772-773.
12. Dameshek, W. (1951) Some speculations on the myeloproliferative syndromes. Blood, 6, 372-375.
13. Dokal, I., Jones, L., Deenmamode, M., Lewis, S.M. & Goldman, J.M. (1989) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 71, 158-160.
14. Dupriez, B., Morel, P., Demory, J.L., Lai, J.L., Simon, M., Plantier, I. & Bauters, F. (1996) Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood, 88, 1013-1018.
15. Garcia, S., Miguel, A., Linares, M., Navarro, M. & Colomina, P. (1989) Idiopathic myelofibrosis terminating in erythroleukemia. American Journal of Hematology, 32, 70-71.
16. Gardner, F.H. & Nathan, D.G. (1966) Androgens and erythropoiesis. III. Further evaluation of testosterone treatment of myelofibrosis. New England Journal of Medicine, 274, 420-426.
17. Gardner, F.H. & Pringle, J.C., Jr (1961) Androgens and erythropoiesis. II. Treatment of myeloid metaplasia. New England Journal of Medicine, 264, 103-111.
18. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipient of marrow from HLA-matched sibling donors. Transplantation, 18, 295-304.
19. Hasselbalch, H. (1990) Primary myelofibrosis: a clinical study of 80 patients. American Journal of Hematology, 34, 291-300.
20. Ifrah, N., Gardembas-Pain, M., Hunault, M., Saint-André, J.P., Foussard, C. & Boasson, M. (1989) Allogeneic bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 73, 575-576.
21. Jouet, J.P., Noël, M.P., Facon, T., Caulier, M.T., Dupriez, B., Gosselin, B., Clincea, R. & Bauters, F. (1994) BMT in a case of primary myelofibrosis (PMF). Bone Marrow Transplantation, 15, 105 (abstract 42).
22. Kalhs, P., Schwarzinger, I., Anderson, G., Mori, M., Clift, R.A., Storb, R., Buckner, C.D., Appelbaum, F.R., Hansen, J.A. & Sullivan, K.M. (1995) A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood, 86, 2028-2032.
23. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
24. Kimura, A., Kawaishi, K., Nakata, Y., Hyodo, H., Kuramoto, A. & Satow, Y. (1995) Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells. Leukemia and Lymphoma, 19, 493-498.
25. Laszlo, J. (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Seminars in Hematology, 12, 409-432.
26. Löfvenberg, E., Wahlin, A., Roos, G. & Öst, A. (1990) Reversal of myelofibrosis by hydroxyurea. European Journal of Haematology, 44, 33-38.
27. Malmaeus, J., Akre, T., Adami, H.O. & Hagberg, H. (1986) Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders. British Journal of Surgery, 73, 720-723.
28. Manoharan, A. & Pitney, W.R. (1984) Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis. Scandinavian Journal of Haematology, 33, 453-459.
29. Marcus, R.E., Hibbin, J.A., Matutes, E., Whittle, N., Waterfield, M.D. & Goldman, J.M. (1986) Megakaryoblastic transformation of myelofibrosis with expression of the c-sis oncogene. Scandinavian Journal of Haematology, 36, 186-193.
30. Morel, P., Demory, J.L. & Dupriez, B. (1997) Relevance of prognostic features in myeloid metaplasia to selection of patients for bone marrow transplantation. Blood, 89, 2219-2220.
31. Nakai, G.S., Craddock, C.G. & Figueroa, W.G. (1962) Primary myelofibrosis: a survey of twenty-nine cases and a review of the literature. Annals of Internal Medicine, 57, 419-440.
32. O'Donnell, M.R., Nademanee, A.P., Snyder, D.S., Schmidt, G.M., Parker, P.M., Bierman, P.J., Fahey, J.L., Stein, A.S., Krance, R.A., Stock, A.D., Forman, S.J. & Blume, K.G. (1987) Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. Journal of Clinical Oncology, 5, 1822-1826.
33. Pitcock, J.A., Reinhard, E.H., Justus, B.W. & Mendelsohn, R.S. (1962) A clinical and pathological study of seventy cases of myelofibrosis. Annals of Internal Medicine, 57, 73-85.
34. Rajantie, J., Sale, G.E., Deeg, H.J., Amos, D., Appelbaum, F., Storb, R., Clift, R.A. & Buckner, C.D. (1986) Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood, 67, 1693-1697.
35. Rosenthal, D.S. & Moloney, W.C. (1977) Occurrence of acute leukaemia in myeloproliferative disorders. British Journal of Haematology, 36, 373-382.
36. Sacchi, S. (1995) The role of α-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update. Leukemia and Lymphoma, 19, 13-20.
37. Schmitz, N., Suttorp, M., Schlegelberger, B., Weber-Matthiesen, K., Tiemann, M. & Sonnen, R. (1992) The role of the spleen after bone marrow transplantation for primary myelofibrosis. British Journal of Haematology, 81, 616-618.
38. Silver, R.T. (1990) Interferons in the treatment of myeloproliferative diseases. Seminars in Hematology, 27, (Suppl. 4), 6-14.
39. Silverstein, M.N. & ReMine, W.H. (1979) Splenectomy in myeloid metaplasia. Blood, 53, 515-518.
40. Singhal, S., Powles, R., Treleaven, J., Pollard, C., Lumley, H. & Mehta, J. (1995) Allogeneic bone marrow transplantation for primary myelofibrosis. Bone Marrow Transplantation, 16, 743-746.
41. Soll, E., Massumoto, C., Clift, R.A., Buckner, C.D., Appelbaum, F.R., Storb, R., Sale, G., Hackman, R. & Martin, P. (1995) Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. Blood, 86, 4667-4673.
42. Sultan, C., Scoazec, J.Y. & Imbert, M. (1991) Histopathologie de la Moelle Osseuse, pp. 74-78. Masson, Paris.
43. Sutton, L., Soussain, S., Travade, P., Binet, J.L. & Leblond, V. (1994) Unusual rise of peripheral blood erythroblasts, preceding neutrophil recovery after allogeneic BMT for primitive myelofibrosis with myeloid metaplasia. Bone Marrow Transplantation, 13, 104.
44. Thiele, J., Kvasnicka, H.M., Steinberg, T., Zankovich, R., Fischer, R. & Diehl, V. (1992) Survival in primary (primary) osteomyelofibrosis, so-called primary myelofibrosis. Leukemia and Lymphoma, 6, 389-399.
45. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neimann, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975) Bone-marrow transplantation. New England Journal of Medicine, 292, 832-843.
46. Varki, A., Lottenberg, R., Griffith, R. & Reinhard, E. (1983) The syndrome of primary myelofibrosis: a clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine, 62, 353-371.
47. Visani, G., Finelli, G., Castelli, U., Petti, M.C., Ricci, N., Vianelli, N., Gianni, L., Zuffa, E., Aloe Spiriti, M.A., Latagliata, R., Pileri, S., Magrini, U., Gugliota, L., Morra, E., Bernasconi, C., Mandelli, F. & Tura, S. (1990) Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. British Journal of Haematology, 75, 4-9.
48. Ward, H.P. & Block, M.H. (1971) The natural history of primary myelofibrosis (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine, 50, 357-420.